News
-
The research progress of opioid peptides from the approval of Difelikefalin
As early as 2021-08-24, Cara Therapeutics and its business partner Vifor Pharma announced that its first-in-class kappa opioid receptor agonist difelikefalin (KORSUVA™) was approved by the FDA for ...Read more